The Advanced Therapeutics in Movement & Related Disorders (ATMRD) Congress is hosted by the Parkinson & Movement Disorder (PMD) Alliance, in partnership with MedStar Georgetown University Hospital. It aims to provide discussion among clinicians of all types to enhance movement disorder clinical practices in a refreshing manner for patients, their support network, and clinicians.
Extended-Release Amantadine Offers More Predictable Good ON Time for Those With Parkinson Disease
June 12th 2023Pooled results of a post hoc analysis from phase 3 studies of amantadine (Gocovri; Supernus) suggest that the therapy offers increased good ON time, and in intervals that are more predictable for patients, compared with placebo.
Increasing Utilization of Deep Brain Stimulation in Clinical Practice: Fiona Gupta, MD
June 12th 2023The assistant professor of neurology and director of the Movement Disorders Outreach Program at Mount Sinai Medical Center shed some light on the use of DBS in the clinic and how it has evolved as a therapeutic option for patients with Parkinson disease. [WATCH TIME: 2 minutes]
Survey Suggests Gaps in Communication With Parkinson Disease Care Partners
June 10th 2023A survey of more than 700 Parkinson disease caregivers highlighted the impact their role has on them emotionally, physically, and mentally, and pointed to several areas of need for support from the clinical community.
Care Access Challenges in Parkinson Disease and Movement Disorders: Fiona Gupta, MD
June 10th 2023The assistant professor of neurology and director of the Movement Disorders Outreach Program at Mount Sinai Medical Center spoke about the challenges with access to care in movement disorders. [WATCH TIME: 2 minutes]
The Expansion of Botulinumtoxin in the Clinical Care of Parkinson Disease: Laxman Bahroo, DO
June 10th 2023The professor of neurology and residency program director at MedStar Georgetown University Hospital discussed the value of educating clinicians on the utility of botulinumtoxins in PD care. [WATCH TIME: 3 minutes]
Ensuring Good Quality of Life With Good ON Time in Parkinson Disease: Khash Dashtipour, MD, PhD
June 9th 2023The director of the Movement Disorders Division at Loma Linda University discussed the importance of understanding good ON time in Parkinson disease care, and how it can influence quality of life. [WATCH TIME: 5 minutes]
Learning From Patients and Looking to the Future of Movement Disorder Care
July 19th 2022Jill Farmer, DO, MPH, director of the Parkinson’s Disease and Movement Disorder Program at Global Neuroscience Institute, spoke at length about the recent ATMRD Congress, the state of care for movement disorders, and her hopes for the horizon of therapy and treatment.
The Need for More Time in Movement Disorder Care: Temitope Lawal, MD
July 19th 2022The neurologist and movement disorders fellow at University Hospitals Cleveland Medical Center spoke about the need for clinicians to have more time with patients in clinical practice, particularly with those with chronic diseases. [WATCH TIME: 2 minutes]
Drawing From Experience When Treating Parkinson Disease: Temitope Lawal, MD
July 14th 2022The neurologist and movement disorders fellow at University Hospitals Cleveland Medical Center spoke about how his experience as a caregiver shapes his perspective as a doctor in care for those with movement disorders. [WATCH TIME: 3 minutes]
Working With Interdisciplinary Teams in Movement Disorders: Temitope Lawal, MD
July 12th 2022The neurologist and movement disorders fellow at University Hospitals Cleveland Medical Center shared his experiences engaging with a diverse community of clinicians at the ATMRD Congress and in clinical practice. [WATCH TIME: 2 minutes]
Learning From Patients With Parkinson Disease: Laxman Bahroo, DO
July 6th 2022The assistant professor of neurology and codirector of the Neurology Residency Program at MedStar Georgetown University Hospital and presenter at ATMRD offered his insight into the benefits of multispecialty meetings. [WATCH TIME: 1 minute]
Benefits From the 2022 ATMRD Congress and Multidisciplinary Teams: Laxman Bahroo, DO
June 30th 2022The assistant professor of neurology and codirector of the Neurology Residency Program at MedStar Georgetown University Hospital and presenter at ATMRD offered his insight into the benefits of multispecialty meetings. [WATCH TIME: 3 minutes]
Awareness of Botulinum Toxins in the Movement Disorder Landscape: Laxman Bahroo, DO
June 29th 2022The assistant professor of neurology and codirector of the Neurology Residency Program at MedStar Georgetown University Hospital shared his thoughts on the 2022 ATMRD Congress and the steps forward made in patient awareness of therapeutic options. [WATCH TIME: 3 minutes]
Interdisciplinary Care and Hot Topics in Movement Disorders: Jill Farmer, DO, MPH
June 25th 2022The director of the Parkinson’s Disease and Movement Disorder Program at Global Neuroscience Institute discussed the importance of a multidisciplinary approach to movement disorders and the hot topics of conversation at ATMRD. [WATCH TIME: 2 minutes]
The ATMRD Congress and Importance of Accessibility as a Clinician: Jill Farmer, DO, MPH
June 23rd 2022The director of the Parkinson’s Disease and Movement Disorder Program at Global Neuroscience Institute spoke about her time at the 2022 ATMRD Congress and how successful communication between patients and providers is rooted in accessibility. [WATCH TIME: 2 minutes]
Apomorphine Sublingual Film Treatment for Parkinson Disease May Not Require Use of Antiemetics
June 20th 2022After a protocol adjustment that disallowed the use of the antiemetic trimethobenzamide during dose-titration, adverse event data from an open-label study of apomorphine sublingual film (Kynmobi; Sunovion) suggest antinausea treatment might not be necessary.